Skip to main content
SpringerLink
Log in

Blockade of human and porcine myocardial 5-HT4 receptors by SB 203186

  • Original Article
  • Published:
Naunyn-Schmiedeberg's Archives of Pharmacology Aims and scope Submit manuscript

Abstract

We investigated the blockade of the positive inotropic effects of 5-hydroxytryptamine (5-HT) by SB 203 186 (piperidinoethyl-indole-3-carboxylate hydrochloride) and its affinity for 5-HT4 receptors of human right atrium and piglet left atrium. We also compared the blocking effects of SB 203 186 against 5-HT-evoked tachycardia in anaesthetised adult Yucatan minipigs as well as new-born Camborough piglets.

SB 203 186 caused competitive antagonism of the positive inotropic effects of 5-HT in electrically paced atrial preparations of man (pK B = 8.9) and piglet (pK B = 8.5) at concentrations (up to 0.3 μmo]/l) which were devoid of depressant or stimulant effects. The affinity of SB 203 186 for atrial 5-HT4 receptors was 30–160 times higher than that of tropisetron. 5-HT caused tachycardia with similar potency and efficacy in Yucatan minipigs and new-born Camborough piglets. SB 203 186 (0.1–3 mg/kg, i.v.) surmountably antagonised 5-HT-evoked tachycardia in anaesthetised Yucatan minipigs or new-born Camborough piglets with similar potency. The blocking potency of SB 203 186 in Yucatan minipigs was 17 times higher than that of tropisetron. Intraduodenally administered SB 203 186 (0.3–3 mg/kg) to new-born Camborough piglets produced blockade of 5-HT-evoked tachycardia which was maximal after 20 min and lasted for more than 3 h with 0.3 mg/kg. The antagonism produced by the SB 203 186 administration in new-born Camborough piglets was dose-related and threefold greater through the intravenous route than through the intraduodenal route.

We conclude that SB 203 186 is an antagonist with nanomolar affinity for both human and porcine atrial 5-HT4 receptor. The in vivo results demonstrate that the sinoatrial 5-HT4 receptors function is similar in new-born Camborough piglets and adult Yucatan minipigs. Both porcine breeds are valid models for human atrial 5-HT4 receptors as demonstrated with the antagonist SB 203186.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  • Arunlakshana O, Schild HO (1959) Some quantitative uses of drug antagonism. Br J Pharmacol Chemother 14:48–58

    Google Scholar 

  • Blinks JR (1965) Convenient apparatus for recording contractions of isolated muscle. J Appl Physiol 20:755–757

    Google Scholar 

  • Buchheit KH, Gamse R, Pfannnkuche H-J (1992)SDZ 205–557, a selective, surmountable antagonist for 5-HT4 receptors in the isolated guinea-pig ileum. Naunyn-Schmiedeberg's Arch Pharmacol 345:387–393

    Google Scholar 

  • Dumuis A, Bouhelal R, Sebben M, Cory R, Bockaert J (1988) A non-classical 5-hydroxytryptamine receptor positively coupled with adenylate cyclase in the central nervous system. Mol Pharmacol 34:880–887

    Google Scholar 

  • Dumuis A, Sebben M, Bockaert J (1989) The gastrointestinal prokinetic benzamide derivatives are agonists at the non-classical 5-HT receptor (5-HT4) positively coupled to adenylate cyclase in neurons. Naunyn-Schmiedeberg's Arch Pharmacol 340:403–10

    Google Scholar 

  • Dumuis A, Gozlan H, Sebben M, Ansanay H, Rizzi CA, Turconi M, Monferini E, Giraldo E, Schiantarrelli P, Ladensky H, Bockaert J (1992) Characterisation of a novel serotonin (5-HT4) receptor antagonist of the azabicycloalkyl benzimidazolone class:DAU 6285. Naunyn-Schmiedeberg's Arch Pharmacol 345:264–269

    Google Scholar 

  • Eglen RM, Alvarez R, Johnson LG, Leung E, Wong EHF (1993) The action of SDZ 205,557 at 5-hydroxytryptamine (5-HT3 and 5HT4) receptors. Br J Pharmacol 108:376–382

    Google Scholar 

  • Gale JD, Grossman CJ, Whitehead JWF, Oxford AW, Bunce KT, Humphrey PPA (1994) GR113808: a novel, selective antagonist with high affinity at the 5-HT4 receptor. Br J Pharmacol 111:332–338

    Google Scholar 

  • Gille E, Lemoine H, Ehle B, Kaumann AJ (1985) The affinity of (-)-propranolol for \1- and \2- adrenoceptors of human heart. Differential antagonism of the positive inotropic effects and adenylate cyclase stimulation by (-)-noradrenaline and (-)-adrenaline. Naunyn-Schmiedeberg's Arch Pharmacol 331:60–70

    Google Scholar 

  • Grossman CJ, Gale JD, Bunce KT, Kilpatrick GJ, Whitehead JWF, Oxford AW, Humphrey PPA (1993) Development of a radioligand binding assay for the 5-HT4 receptor: use of a novel antagonist. Br J Pharmacol 108:106p

  • Harding SE, del Monte F, Kaumann AJ (1994)Atrial myocytes from patients taking \-blockers have increased positive inotropic responses to 5-hydroxytryptamine, Eur Heart J 15 [Suppl]: P1130

    Google Scholar 

  • Jahnel U, Rupp J, Ertl R, Nawrath H (1992) Positive inotropic responses to 5-HT in human atrial but not in ventricular heart muscle. Naunyn-Schmiedeberg's Arch Pharmacol 346:482–485

    Google Scholar 

  • Kaumann AJ (1990) Piglet sinoatrial 5-HT receptors resemble human atrial 5-HT4-like receptors. Naunyn-Schmiedeberg's Arch Pharmacol 342:619–622

    Google Scholar 

  • Kaumann AJ (1993) Blockade of human atrial 5-HT4 receptors by GR 113808. Br J Pharmacol 110:1172–1174

    CAS  PubMed  Google Scholar 

  • Kaumann AJ (1994) Do human 5-HT4 receptors mediate arrhythmias? Trends Pharmacol Sci 15:451–455

    Google Scholar 

  • Kaumann AJ, Sanders L (1994) 5-Hydroxytryptamine causes rate-dependent arrhythmias through 5-HT4 receptors in human atrium: facilitation by chronic \-adrenoceptor blockade. Naunyn-Schmiedeberg's Arch Pharmacol 349:331–337

    Google Scholar 

  • Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1990) A 5-hydroxytryptamine receptor in human atrium. Br J Pharmacol 100:879–885

    CAS  PubMed  Google Scholar 

  • Kaumann AJ, Sanders L, Brown AM, Murray KJ, Brown MJ (1991a) A 5-HT4-like receptor in human right atrium. Naunyn-Schmiedeberg's Arch Pharmacol 344:150–159

    Google Scholar 

  • Kaumann AJ, Brown AM, Raval P (1991b) Putative 5-HT4-like receptors in piglet left atrium. Br J Pharmacol 102:98P

    Google Scholar 

  • Kaumann AJ, Raval P, Medhurst A (1991c) Both siguazodan and rolipram increase positive inotropic responses to 5-hydroxytryph tamine in piglet left atria. Naunyn-Schmiedeberg's Arch Pharmacol 343: R100

    Google Scholar 

  • Kaumann AJ, Medhurst A, Boyland P, Vimal M, Young RC (1993) SB 203186, a potent 5-HT4 receptor antagonist for cardiac 5-HT4 receptors. In: Vanhoutte PM et al. (eds) Serotonin. Kluwer, London, pp 135–139

    Google Scholar 

  • Kaumann AJ, Gaster LM, King FD, Brown AM (1994) Blockade of human atrial 5-HT4 receptors by SB 207710, a selective and high affinity 5-HT4 receptor antagonist. Naunyn-Schmiedeberg's Arch Pharmacol 348:546–548

    Google Scholar 

  • Kaumann AJ, Lynham JA, Brown AM (1995a) Labelling with [125I]-SB 207710 of a small 5-HT4 receptor population in piglet right atrium: functional relevance. Br J Pharmacol 115:933–936

    CAS  PubMed  Google Scholar 

  • Kaumann AJ, Lynham JA, Brown AM (1995b) [125I]-SB 207710 labels small 5-HT4 receptor populations in porcine and human atrium. Br J Pharmacol 116:39P

  • Lorrain J, Grosset A, O'Connor SE (1993) 5-HT4 receptors, present in piglet atria and sensitive to SDZ 205–557, are absent in papillary muscle. Eur J Pharmacol 229:105–108

    Google Scholar 

  • Medhurst AD, Kaumann AJ (1993) Characterisation of the 5-HT4 receptor mediating tachycardia in isolated piglet right atrium. Br J Pharmacol 110:1023–1030

    Google Scholar 

  • Ouadid H, Seguin J, Dumuis A, Bockaert J, Nargeot J (1991) Serotonin increases calcium current in human atrial myocytes via the newly described 5-hydroxytryptamine4 receptors. Mol Pharmacol 41:346–351

    Google Scholar 

  • Parker SG, Hamburger S, Taylor EM, Kaumann AJ (1993) SB203186, a potent 5-HT4 receptor antagonist in porcine sinoatrial node and human and porcine atrium. Br J Pharmacol 108:68P

    Google Scholar 

  • Sanders L, Kaumann AJ (1992) A 5-HT4-like receptor in human left atrium. Naunyn-Schmiedeberg's Arch Pharmacol 345: 382–386

    Google Scholar 

  • Turconi M, Schianterelli P, Borsini F, Rizzi CA, Ladinsky H, Donetti A (1991) Azabicycloalkyl benzimidazolones: Interaction with serotonergic 5-HT3 and 5-HT4 receptors and potential therapeutic implications. Drugs of the future 16:1011–1026

    Google Scholar 

  • Van Meel JCA, Diederen W, Haigh R, Wienen W, Pairet M, Turconi M, Doods HN (1993) The novel 5-HT4 receptor antagonist DAU 6285 antagonizes 5-hydroxytryptamine-induced tachycardia in pigs. Eur J Pharmacol 233:295–297

    Google Scholar 

  • Villalon CM, den Boer MO, Heiligers JPC, Saxena PR (1990) Mediation of 5-hydroxytryptamine-induced tachycardia in pig by the putative 5-HT4 receptor. Br J Pharmacol 100:665–667

    Google Scholar 

  • Villalon CM, den Boer MO, Heiligers JPC, Saxena PR (1991) Further characterisation, by use of tryptamine and benzamide derivatives, of the putative 5-HT4 receptor mediating tachycardia in the pig. Br J Pharmacol 102:107–112

    Google Scholar 

  • Zerkowski H-R, Broede A, Kunde S, Hilleman S, Schäfer E, Vogelsang M, Michel MC, Broede O-E (1993) Comparison of the positive inotropic effects of serotonin, histamine, angiotensin II, endothelin and isoprenaline in the isolated human atrium. Naunyn-Schmiedeberg's Arch Pharmacol 347: 347–52

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Smith Kline Beecham Pharmaceuticals, AL6 9AR, The Frythe, Welwyn, UK

    Stephen G. Parker & E. Michael Taylor

  2. Eli Lilly Pharmaceuticals, 46285, Indianapolis, IN, USA

    Steven A. Hamburger

  3. Imperial College, Department of Chemistry, SW7 2AZ, London

    Mythily Vimal

  4. Human Pharmacology Laboratory, The Babraham Institute, C132 4AT, Cambridge, UK

    Alberto J. Kaumann

Authors
  1. Stephen G. Parker
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Michael Taylor
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steven A. Hamburger
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Mythily Vimal
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Alberto J. Kaumann
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Parker, S.G., Taylor, E.M., Hamburger, S.A. et al. Blockade of human and porcine myocardial 5-HT4 receptors by SB 203186. Naunyn-Schmiedeberg's Arch Pharmacol 353, 28–35 (1995). https://doi.org/10.1007/BF00168912

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00168912

Key words

Search

Navigation